Form 8-K - Current report:
SEC Accession No. 0001654954-24-014016
Filing Date
2024-11-08
Accepted
2024-11-08 13:39:20
Documents
17
Period of Report
2024-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K zom_8k.htm   iXBRL 8-K 26461
2 PRESS RELEASE zom_ex991.htm EX-99.1 35101
8 zom_ex991img2.jpg GRAPHIC 47638
  Complete submission text file 0001654954-24-014016.txt   247427

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zom-20241107.xsd EX-101.SCH 5881
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE zom-20241107_lab.xml EX-101.LAB 14091
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zom-20241107_cal.xml EX-101.CAL 905
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zom-20241107_pre.xml EX-101.PRE 8902
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zom-20241107_def.xml EX-101.DEF 2106
20 EXTRACTED XBRL INSTANCE DOCUMENT zom_8k_htm.xml XML 3742
Mailing Address 100 PHOENIX DRIVE SUITE 125 ANN ARBOR MI 48108
Business Address 100 PHOENIX DRIVE SUITE 125 ANN ARBOR MI 48108 (734) 369-2555
Zomedica Corp. (Filer) CIK: 0001684144 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38298 | Film No.: 241439331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)